Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of the Fatty Liver Index in Primary Care for Patients at Risk of Hepatic Steatosis to Optimize Clinical Control: Randomized Clinical Trial

NCT06363617 is registered in ClinicalTrials.gov with Consorci Sanitari de l'Alt Penedès i Garraf as lead sponsor.

NCT NCT06363617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06363617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of the Fatty Liver Index in Primary Care for Patients at Risk of Hepatic Steatosis to Optimize Clinical Control: Randomized Clinical Trial
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Phase
Not applicable
Overall status
Completed
Start date
May 2, 2024
Completion date
February 1, 2025
Enrollment
434 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic steatosis, overweight and obesity